Analysts Set Sutro Biopharma, Inc. (NASDAQ:STRO) Target Price at $37.38
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has issued a hold recommendation, seven have given a buy recommendation and […]
15 Apr 02:16 · The Cerbat Gem